M. Evans

First name
M.
Last name
Evans
James, G., Kim, J., Mellström, C., Ford, K. L., Jenkins, N. C., Tsang, C., et al. (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758-770. http://doi.org/10.1093/ckj/sfab225
Currie, C. J., Peters, J. R., Tynan, A., Evans, M., Heine, R. J., Bracco, O. L., et al. (2010). Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. http://doi.org/10.1016/s0140-6736(09)61969-3
Sazonov, V., Beetsch, J., Phatak, H., Wentworth, C., & Evans, M. (2010). Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database. Atherosclerosis. http://doi.org/10.1016/j.atherosclerosis.2009.07.021
Morgan, C. L., Jenkins-Jones, S., Evans, M., Barnett, A. H., Poole, C. D., & Currie, C. J. (2012). Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes Obes Metab. http://doi.org/10.1111/j.1463-1326.2011.01552.x
Morgan, C. L., Poole, C. D., Evans, M., Barnett, A. H., Jenkins-Jones, S., & Currie, C. J. (2012). What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3034
Suissa, S., Azoulay, L., Dell'Aniello, S., Evans, M., Vora, J., & Pollak, M. (2011). Long-term effects of insulin glargine on the risk of breast cancer. Diabetologia. http://doi.org/10.1007/s00125-011-2190-9
Currie, C. J., Poole, C. D., Evans, M., Peters, J. R., & Morgan, C. L. (2013). Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab. http://doi.org/10.1210/jc.2012-3042
McEwan, P., Thorsted, L., Wolden, M., Jacobsen, J., & Evans, M. (2015). Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2014-000057
Nyeland, M. E., Ploug, U. J., Richards, A., Alvarez, G., Demuth, D., Muthutantri, A., et al. (2015). Evaluation of the effectiveness of liraglutide and sitagliptin in type 2 diabetes: a retrospective study in UK primary care. Int J Clin Pract. http://doi.org/10.1111/ijcp.12575
Gordon, J. P., Evans, M., Puelles, J., & McEwan, P. C. (2015). Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy. Diabetes Ther. http://doi.org/10.1007/s13300-015-0134-y